US$ 27.47
henry's glp 1 GLP-1 Hims Inc. - Hims &
Description
Companies that sell compounded medications should disclose that these drugs are not FDA-approved and haven't undergone the same rigorous testing for safety and effectiveness as FDA-approved drugs

This creates a potential valuation disconnect compared with large-cap pharmaceutical incumbents and later-stage obesity therapy developers, particularly if the company successfully achieves meaningful clinical and regulatory milestones

V., Sun J., Hwang I.-W., et al

Noticeable results are often observed within weeks of commencing semaglutide

It is widely used in brain supplements for clarity and focus
